301 related articles for article (PubMed ID: 32295300)
1. Natural Bioactive Compounds from Fungi as Potential Candidates for Protease Inhibitors and Immunomodulators to Apply for Coronaviruses.
Suwannarach N; Kumla J; Sujarit K; Pattananandecha T; Saenjum C; Lumyong S
Molecules; 2020 Apr; 25(8):. PubMed ID: 32295300
[TBL] [Abstract][Full Text] [Related]
2. Recent Advances in the Discovery of Potent Proteases Inhibitors Targeting the SARS Coronaviruses.
Sharma A; Kaliya K; Maurya SK
Curr Top Med Chem; 2021; 21(4):307-328. PubMed ID: 33183205
[TBL] [Abstract][Full Text] [Related]
3. Putative Inhibitors of SARS-CoV-2 Main Protease from A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study.
Gentile D; Patamia V; Scala A; Sciortino MT; Piperno A; Rescifina A
Mar Drugs; 2020 Apr; 18(4):. PubMed ID: 32340389
[TBL] [Abstract][Full Text] [Related]
4. Protease inhibitors broadly effective against feline, ferret and mink coronaviruses.
Perera KD; Galasiti Kankanamalage AC; Rathnayake AD; Honeyfield A; Groutas W; Chang KO; Kim Y
Antiviral Res; 2018 Dec; 160():79-86. PubMed ID: 30342822
[TBL] [Abstract][Full Text] [Related]
5. Diversity, molecular mechanisms and structure-activity relationships of marine protease inhibitors-A review.
Rauf A; Khalil AA; Olatunde A; Khan M; Anwar S; Alafnan A; Rengasamy KR
Pharmacol Res; 2021 Apr; 166():105521. PubMed ID: 33662574
[TBL] [Abstract][Full Text] [Related]
6. Recent progress in the discovery of inhibitors targeting coronavirus proteases.
Wang H; Xue S; Yang H; Chen C
Virol Sin; 2016 Feb; 31(1):24-30. PubMed ID: 26920707
[TBL] [Abstract][Full Text] [Related]
7. Natural Polysaccharides with Immunomodulatory Activities.
Zhao Y; Yan B; Wang Z; Li M; Zhao W
Mini Rev Med Chem; 2020; 20(2):96-106. PubMed ID: 31518223
[TBL] [Abstract][Full Text] [Related]
8. Anticoronavirus and Immunomodulatory Phenolic Compounds: Opportunities and Pharmacotherapeutic Perspectives.
Dejani NN; Elshabrawy HA; Bezerra Filho CDSM; de Sousa DP
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439920
[TBL] [Abstract][Full Text] [Related]
9. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
[TBL] [Abstract][Full Text] [Related]
10. Drug targets in severe acute respiratory syndrome (SARS) virus and other coronavirus infections.
Tong TR
Infect Disord Drug Targets; 2009 Apr; 9(2):223-45. PubMed ID: 19275708
[TBL] [Abstract][Full Text] [Related]
11. Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor.
Kim Y; Liu H; Galasiti Kankanamalage AC; Weerasekara S; Hua DH; Groutas WC; Chang KO; Pedersen NC
PLoS Pathog; 2016 Mar; 12(3):e1005531. PubMed ID: 27027316
[TBL] [Abstract][Full Text] [Related]
12. Optimization Rules for SARS-CoV-2 M
Stoddard SV; Stoddard SD; Oelkers BK; Fitts K; Whalum K; Whalum K; Hemphill AD; Manikonda J; Martinez LM; Riley EG; Roof CM; Sarwar N; Thomas DM; Ulmer E; Wallace FE; Pandey P; Roy S
Viruses; 2020 Aug; 12(9):. PubMed ID: 32859008
[TBL] [Abstract][Full Text] [Related]
13. Broad-spectrum inhibitors against 3C-like proteases of feline coronaviruses and feline caliciviruses.
Kim Y; Shivanna V; Narayanan S; Prior AM; Weerasekara S; Hua DH; Kankanamalage AC; Groutas WC; Chang KO
J Virol; 2015 May; 89(9):4942-50. PubMed ID: 25694593
[TBL] [Abstract][Full Text] [Related]
14. 3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice.
Rathnayake AD; Zheng J; Kim Y; Perera KD; Mackin S; Meyerholz DK; Kashipathy MM; Battaile KP; Lovell S; Perlman S; Groutas WC; Chang KO
Sci Transl Med; 2020 Aug; 12(557):. PubMed ID: 32747425
[TBL] [Abstract][Full Text] [Related]
15. Oceans as a Source of Immunotherapy.
Ahmad B; Shah M; Choi S
Mar Drugs; 2019 May; 17(5):. PubMed ID: 31083446
[TBL] [Abstract][Full Text] [Related]
16. Structure of M
Jin Z; Du X; Xu Y; Deng Y; Liu M; Zhao Y; Zhang B; Li X; Zhang L; Peng C; Duan Y; Yu J; Wang L; Yang K; Liu F; Jiang R; Yang X; You T; Liu X; Yang X; Bai F; Liu H; Liu X; Guddat LW; Xu W; Xiao G; Qin C; Shi Z; Jiang H; Rao Z; Yang H
Nature; 2020 Jun; 582(7811):289-293. PubMed ID: 32272481
[TBL] [Abstract][Full Text] [Related]
17. Structure-Based Discovery and Structural Basis of a Novel Broad-Spectrum Natural Product against the Main Protease of Coronavirus.
Zhang Y; Gao H; Hu X; Wang Q; Zhong F; Zhou X; Lin C; Yang Y; Wei J; Du W; Huang H; Zhou H; He W; Zhang H; Zhang Y; McCormick PJ; Fu J; Wang D; Fu Y; Lu X; Zhang T; Duan J; Qin B; Jiang H; Luo J; Zhang Y; Chen Q; Luo Q; Cheng L; Zhang Z; Zhang J; Li J
J Virol; 2022 Jan; 96(1):e0125321. PubMed ID: 34586857
[TBL] [Abstract][Full Text] [Related]
18. Antiviral fungal metabolites and some insights into their contribution to the current COVID-19 pandemic.
Takahashi JA; Barbosa BVR; Lima MTNS; Cardoso PG; Contigli C; Pimenta LPS
Bioorg Med Chem; 2021 Sep; 46():116366. PubMed ID: 34438338
[TBL] [Abstract][Full Text] [Related]
19. A Comprehensive Review of Bioactive Peptides from Marine Fungi and Their Biological Significance.
Youssef FS; Ashour ML; Singab ANB; Wink M
Mar Drugs; 2019 Sep; 17(10):. PubMed ID: 31569458
[TBL] [Abstract][Full Text] [Related]
20. Peptidomimetic therapeutic agents targeting the protease enzyme of the human immunodeficiency virus and hepatitis C virus.
Tsantrizos YS
Acc Chem Res; 2008 Oct; 41(10):1252-63. PubMed ID: 18681464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
